Opioid Substitution Treatment Clinics, Patients, Staff
Conditions
Keywords
Implementation Science, Methadone treatment, Opioid Use Disorder, Opioid Use Disorder Treatment, Workforce Development, Vicarious trauma, Posttraumatic stress, Treatment retention
Brief summary
Examine the preliminary effect of the MPACT intervention on methadone treatment retention, in treatment overdose and patient trauma symptoms. The study will also explore the relationship between staff trauma symptoms and MPACT implementation.
Detailed description
Specific AIMS: AIM 1: Develop MPACT through multilevel, iterative planning with OTP staff and people with recent MMT experience. AIM 2: Conduct a 4-month MPACT pilot test in two AZ OTPs: Mesa (urban) with 50 patients and 22 staff, and Sierra Vista (rural-serving) with 50 patients and 8 staff to: 1. Determine MPACT implementation feasibility, acceptability, and preliminary effect on MMT practice change and culture. 2. Determine MPACT preliminary effect on MMT retention, in-MMT overdose, and patient PTSS. 3. Characterize staff trauma history, PTSS and vicarious trauma, and explore their relationship with MPACT acceptability and implementation fidelity. AIM 3: Characterize MPACT acceptability, likely adoption, and recruitment feasibility among directors, case managers and counselors from a national random sample of 500 OTPs.
Interventions
OTHERMPACT Intervention
MPACT has 4 components: accredited training about patient centered, trauma informed methadone treatment, staff education about trauma symptoms with navigation to self screening and treatment or stress management, clinic self assessment tools for trauma informed, patient centered care, and reflective supervision for counselors, case managers and peer staff.
Sponsors
University of Arizona
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Intervention model description
This is a pilot implementation and preliminary effectiveness study of MPACT.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Staff of enrolled opioid treatment programs (methadone clinics) who are involved with methadone treatment * Patients receiving methadone at these locations
Exclusion criteria
* Patients not receiving methadone at these locations * Staff not involved in methadone treatment at these locations
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| methadone treatment retention | 4 months (pilot study period) | Retention in methadone treatment (measured by 3 different indicators) |
| In treatment overdose | 4 months (pilot study period) | Reported overdoses during methadone treatment (measured by study constructed algorithm) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Trauma symptoms among patients and staff | pilot period of 4 months | Post traumatic stress symptoms (measured by 8-item Post Traumatic Stress Disorder Checklist or, PCL-5). Scores are 0-80. Higher scores mean greater PTSD symptom severity. |
| Vicarious Trauma symptoms among staff | pilot period of 4 months | Vicarious trauma symptoms (measured by the Vicarious Trauma Scale (VTS). Scores are 0-190. Higher scores indicate more vicarious (work related) traumatization. |
Countries
United States
Outcome results
None listed